tree analysis revealed that six of the patients harboured very similar strains and clustered together, including Background. Haemodialysis patients are at high risk of infection by hepatitis C virus. The aim of this study all incident and one prevalent case, which was implicated as index case. Further epidemiological analysis was to investigate a hepatitis C virus outbreak which occurred in a haemodialysis unit, using epidemiological was consistent with patient to patient transmission.
HCV infection in a haemodialysis unit. Molecular analysis of viral strains in association with epidemiological data reconstructed the plausible routes of transmission and provided evidence for a patient to patient nosocomial infection.
Subjects and methods

Haemodialysis procedure
At the time of the outbreak, 40 patients were regularly dialysed, on one of the two shifts per day (either morning or evening shift), 3 times per week on either a MondayWednesday-Friday or a Tuesday-Thursday-Saturday schedule. Thus, every dialysis machine was used by two persons per day. Patients were normally dialysed on the same shift and on the same console although exceptions could occur and these were recorded. The dialysis unit employed one large room with 10 dialysis machines (consoles no. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] and a small room with one dialysis machine (console no. 11). Consoles no. 1-9 were used by all anti-HCV-positive and -negative patients, who were not separated, and shared the same dialysis machines. One dialysis machine was dedicated to patients in critical condition (console no. 10) and another machine in the small room (console no. 11) to HBsAg-positive patients ( Figure 1 ). Nurses worked in two shifts per day and had to take care of three patients per shift, but they could also move from patient to patient if needed.
Haemodialysis was carried out using Gambro dialysis machines (Ab, Sweden, AK-10) and bicarbonate as dialysate. All patients were receiving heparin and dialysers were never reused. Machines were heat disinfected between treatments and chemically every month. AK-10 machines do not allow for the dialysis procedure to start if the disinfection cycle 
Data collection
Friday evening, C: Tuesday-Thursday-Saturday morning, D: Tuesday-Thursday-Saturday evening).
The renal dialysis unit started its function in the beginning of 1989. Screening of anti-HCV antibodies and monitoring of alanine aminotransferase (ALT ) was part of the haemo-Hepatitis C serology dialysis unit routine since December 1989. By May 1993 an intensive serological follow-up study was initiated in all Routine detection of anti-HCV begun in December 1989, haemodialysed patients as part of the Multicenter when the first generation enzyme immunoassay (ELISA) Haemodialysis Cohort Study on Viral Hepatitis. Blood became available. A second generation immunoassay was samples were collected every 2 weeks from anti-HCV-adopted in June 1991 (Abbott's Labs, Wiesbaden, Germany). negative patients and every 4 weeks from anti-HCV-positive All anti-HCV positive patients included in the study were ones. Blood was centrifuged within 2 h from collection to confirmed by a second or third generation recombinant achieve optimal conditions for HCV RNA detection. ALT immunoblot assay (Riba-2; HCV-2.0 SIA or Riba-3; HCVlevels were recorded and multiple serum aliquots from each 3.0 SIA, Chiron Corp., Emeryville, CA, USA). bleed were kept at −70°C until further use. Medical records were kept constantly for all patients as
Hepatitis C virus RNA quantification, extraction, part of the haemodialysis unit routine. These records included data such as symptoms of hepatitis, history of liver enzyme amplification and genotyping abnormalities, medication history, past medical history and history of transfusions. Furthermore, the dialysis schedule The detection of HCV RNA was carried out with the Amplicor HCV Test (Roche Diagnostic Systems Inc., (day and shift), seating arrangement (Figure 1 ), bleeding episodes, staff-patient assignments, work schedules, dialysis Branchburg, NJ, USA) [27] . For the quantification of HCV RNA QuantiplexTM HCV RNA 2.0 Assay (bDNA), (Chiron equipment maintenance as well as infection control practices were all recorded. Demographic and risk factors data Dignostics), was used. The determination of HCV genotypes was done on amplicons (generated by the Amplicor HCV including information on intravenous drug use, household contact with any hepatitis case, occupational exposure to Test), using a commercially available assay (Inno-Lipa HCV II, Innogenetics N.V, Zwijndrecht, Belgium). The last is a human blood and temporary dialysis in other centres, were also available.
reverse amplification assay based on the hybridization of the amplified sequence from the 5∞-non coding region of HCV 100 ml of serum or plasma using a mono-phasic solution of phenol and guanidine isothiocyanate (TrizolTM LS Reagent, with oligonucleotide probes immobilized as parallel lines on membrane strips [28] . The probes correspond to the sequence Gibco BRL, Grand Island, NY, USA), according to manufacturers instructions. The final product was dissolved in of the six more common HCV genotypes and their subtypes. The nomenclature system proposed by Simmonds et al. was 20 ml of RNase-free water. Reverse transcription was done using the Gene Amp RNA PCR Kit (Perkin Elmer Cetus, used [29] .
To obtain sequences from the NS5 region of the viral Branchburg, NJ, USA), in a total volume of 20 ml with 50 units of MuLV reverse transcriptase and random hexamers. genome, HCV RNA extraction, reverse transcription and amplification were done as follows: RNA was extracted from The PCR reaction was carried out under standard conditions, Cetus, Branchburg, NJ, USA), in a total volume of 100 ml on a DNA Thermal Cycler (Perkin Elmer Cetus 2400 bodies, whereas the five were incident cases that seroconverted to anti-HCV between May and October 1993. All the other patients of the unit were negative Sequencing and phylogenetic analysis of viral strains for HCV RNA and did not develop anti-HCV antibodAmplified DNA was purified by the GeniePrep DNA ies until the end of the study. The five new cases of isolation kit and directly subjected to double strand sequen-hepatitis C concerned patients who had never been cing with dye-labelled dideoxy terminators. The ABI PRISM transfused or had no transfusions of blood or blood 377 automated sequencer (Applied Biosystems) was used for products in the 14 months preceding seroconversion.
electrophoresis and data collection.
Moreover, none of them had any other identifiable DNA sequences were edited and assembled using risk factor for HCV infection. It should be also noted Sequencer software (Macintosh release 3.0). Clustal V was that all members of the staff were regularly checked used for multiple sequence alignment of DNA sequences for HCV antibodies and were repeatedly found nega- Genotyping using primers from the 5∞-non-coding All the NS5 sequences were compared with each other and region (Inno-Lipa) revealed that seven out of the eight with selected HCV sequences of genotypes 1, 2, 3 and 4 from HCV RNA-positive patients belonged to subtype 4c/d GenBank. Phylogenetic tree analysis was done by the (discrimination between subtypes 4c and 4d with Innoneighbour-joining method using Kimura's two parameter Lipa method is not possible), including all the new correction, as implemented in the PHYLIP package [35] . To seroconversions, whereas one patient was genotyped further confirm the reliability of the phylogenetic tree, 1a ( Table 1) . BOOTSTRAPPING (1000 replicates) was accomplished.
Sequences in the NS5 region of the viral genome were obtained with primers 242, 243 for all the HCV
Results
RNA positive patients of the study. In all cases, the first available serum sample with documented viraemia for hepatitis C was selected for sequence analysis (no Six patients who had been on haemodialysis were found positive for anti-HCV with 2nd generation HCV serum samples were available before May 1993). Two other HCV RNA-positive patients, completely unreassays (June 1991). During 1992 three of these died, and one other patient seroconverted to anti-HCV (July lated to the haemodialysis unit (Co1 and Co2), which were classified as 1b and 4 respectively by Inno-Lipa, 1992). No further seroconversions were observed until an outbreak of HCV infection was recorded between were used as controls.
Phylogenetic tree analysis confirmed the HCV genoMay and October 1993, when five new seroconversions to anti-HCV were noted ( Table 1 ). At that time, the typing results obtained by Inno-Lipa for all the patients and controls, except for patient HD 819 who did not prevalence of anti-HCV in the haemodialysis unit was found to be 22.5%, which is much higher than the one fall within the 4c clade, although it clearly clusters with type 4 isolates, as indicated by high bootstrap reported for the general population (1.0% in our region). After October 1993, no more seroconversions values (99%). In addition, genotyping by sequencing the NS5 region for the second control patient (Co2) occurred till the end of follow-up (October 1997).
A more intensive follow-up started in May 1993 was more precise than Inno-Lipa since it was clustered with the 4c group. with weekly or biweekly collection of samples when all
The very close relation between the six haemodialysis obtained from the 5∞-untranslated region of the viral genome. patients (HD 836, HD 807, HD 806, HD 804, HD 813, HD 816) which formed a distinct cluster, as well Based on genotyping by Inno-Lipa, the suspected index cases were HD 819 or HD 836 or both. Both as the high bootstrap values (1000 of 1000), clearly points towards a common source of infection. Four were of genotype 4 and known carriers before the present outbreak (June 1991 and July 1992 for HD out of six patients (HD 804, HD 816, HD 836, HD 813) displayed identical nucleotide sequences, and the 819 and HD 836, respectively). Phylogenetic tree analysis of the NS5 region ruled out that HD 819 was two remaining (HD 806, HD 807) had one nucleotide substitution each. Phylogenetic analysis also revealed the index case. On the contrary, the same phylogenetic tree analysis placed the six remaining patients (HD that (i) patient HD 819 was not associated with the outbreak and (ii) the index case was HD 836 who 836, HD 807, HD 806, HD 804, HD 813, HD 816) in the same cluster. This cluster included the five new seroconverted to anti-HCV in July 1992. It should be also noted that in May 1993 HD 836 presented HCV cases and patient HD 836 who was anti-HCV positive since July 1992, thus strongly suggesting that the latter RNA levels 1.13×106 Equivalents/ml and had ALT levels 104 IU/ml.
was the index case of the outbreak. Looking back to the epidemiological data it was found out that (i) patient HD 836 was regularly dialysed in the same shift with patient HD 813 (every
Discussion
Tuesday-Thursday-Saturday evening) from September 1992 and during the whole of 1993, but never shared the same dialysis machine suggesting the horizontal There is much evidence supporting the nosocomial transmission of HCV infection among the haemo-mode of transmission as the most probable explanation and (ii) four out of the five patients who seroconverted dialysis patients of this study: (i) the existence of five seroconversions, which took place over a 6 month between May and October 1993 (HD 804, HD 806, HD 807, HD 816) were dialysed in the same morning period and was observed in non-transfused patients, (ii) the finding of a single hepatitis C virus genotype shift (every Monday, Wednesday and Friday) when patient HD 836 was not regularly served. Nevertheless, (type 4) in all the patients of the outbreak, (iii) the extremely high prevalence of genotype 4 among the according to the phylogenetic analysis, the infection presumably passed from patient HD 836 to the mornanti-HCV positive patients of the haemodialysis unit (77.8%), a genotype which is relatively rare in Greece ing shift. Careful review of epidemiological records revealed that although patient HD 836 was regularly (5%, in chronic hepatitis C patients, unpublished data) and (iv) the close relationship of the NS5 amplified treated in the evening shift D, he exceptionally attended the morning shift A (console no. 10) once on Monday sequences between the six haemodialysis patients as shown by phylogenetic tree analysis.
February 1, 1993. While anti-HCV seroconversions started in May 1993, late seroconversion to anti-HCV That nosocomial transmission was implicated, became apparent when molecular epidemiological is well documented among haemodialysis patients [47] [48] [49] . These patients can be viraemic and therefore studies were undertaken which included sequencing of the NS5 region of the HCV genome. The NS5 region able to transmit hepatitis C, but anti-HCV is not detected for a relatively longer period of time. Thus, has been used before for analogous studies [25, 36 ] . Its suitability for phylogenetic analysis relies on the fact it is possible that one or more patients of the morning shift were accidentally infected in February 1993 and, that it is relatively well conserved and therefore sequence changes in that part of the HCV genome, are being viraemic, they passed the transmission to the rest of the patients of the morning shift during the slow enough to preserve evidence of relatedness over a considerable period of time [36 ] . Although the following months (horizontal mode of transmission).
Patients HD 836 and HD 816 shared the same hypervariable region (HVR) of the E2 gene of hepatitis C has been used by many investigators for molecular dialysis machine. However, a vertical route of transmission through the dialysis machines is a very remote epidemiology studies [37] [38] [39] [40] [41] [42] [43] , it is believed that a higher rate of sequence changes might hinder attempts probability since patient HD 836 used to be in the Tuesday-Thursday-Saturday evening shift, after which to link contact to the source of infection, as has been shown with the analogous V3 region of the envelope the dialysis machines were routinely carefully disinfected and dried. The unit was ending its operation gene of HIV [44, 45] and might lead to underrecognition of clusters infected from a common source, around 20.00 h starting again next morning (MondayWednesday-Friday) around 08.00 h and it was in this especially when samples are taken several years after infection [46 ] . Moreover our efforts to amplify HVR shift that patient HD 816 was dialysed. It is also worth mentioning that AK-10 machines do not allow for the in genotype 4 samples, from various transmission groups was unsuccessful (data not shown). A similar dialysis procedure to start if the disinfection cycle has not been completed; they drain utterly following disinepidemiological problem, the high prevalence of hepatitis C genotype 4 virus in patients treated in the same fection and no dialysate recirculation takes place in any part of the hydraulic circuit. haemodialysis unit, was studied by Sampietro et al.
[22] using single strand confirmation polymorphism Retrospective analysis of probable risk practices suggested that the vehicle of transmission was a nurse (SSCP) analysis of polymerase chain reaction products 
